While there is no clear evidence that GLP-1 medications can increase chances of pregnancy, there is a strong correlation ...

Sanofi and Sudair Pharma Company (SPC) have joined forces to establish a state-of-the-art manufacturing facility within the Kingdom of Saudi Arabia, dedicated to the full production including delivery ...

Toujeo (insulin glargine) is a brand-name drug that’s prescribed for type 1 or type 2 diabetes. The medication is available in these forms: Toujeo SoloStar insulin pen and Toujeo Max SoloStar ...

Find patient medical information for Insulin Glargine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

NAIROBI, Kenya, July 18 - The Pharmacy and Poisons Board (PPB) has issued a public warning over falsified diabetes drugs - Ozempic Pens (Semaglutide) in the Kenyan market.

According to the Board, healthcare providers are prescribing Apidra Solostar Pens, which are intended for treating type 1 and 2 diabetes and relabelling them as Ozempic Pens. "The Pharmacy and ...

How Was It Studied for Diabetes? Overall, there were five early studies that all lasted 26 weeks (about 6 months). These studies included one in adults with type 1 diabetes, one in children with ...

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM, about situations in which an ultra-long-acting insulin may be a good choice. Weiner: More ...

Insulin pens can make diabetes management easier, and they are getting easier to use and “smarter” by the day. Here’s a guide to their use and how their design is advancing.

Of the 33 that were drug-device combinations, 63% of those patents were related to the delivery devices rather than the insulin itself. Sanofi's Lantus (glargine) Solostar, for example, had 18 ...